| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |